September 27, 2007 - Sutura Inc., a developer of minimally invasive vascular suturing devices, announced today that the first patient to receive a SuperStitch EL to close a Patent Foramen Ovale (PFO) is showing no left-to-right shunt, demonstrating that a single stitch delivered percutaneously by a transcatheter technique is possible.
Doctors at Republic Hospital in Tbilisi, Georgia performed a Tranesophageal Echo (TEE) on the patient and reported that the 19-year-old female patient is clinically doing well one month after the closure of the PFO using the SuperStitch EL.
“The patient not only is asymptomatic and doing well clinically, but now the TEE with bubble-contrast study at one month post closure confirms that a single stitch delivered percutaneously by a transcatheter technique is feasible. This new revolutionary technique may indeed initiate a paradigm shift in the rational approach to how and to whom PFO should be closed,” commented Dr. Carlos E. Ruiz, Director, Structural and Congenital Heart Disease at Lenox Hill Hospital, New York.
For more information: www.suturaus.com